Detail of the session
Type :
DISCUSSED E-POSTERS
DISCUSSED E-POSTERS
Date :
Saturday 27th April 2019
Saturday 27th April 2019
Schedule :
10h10 - 10h25
10h10 - 10h25
Session Title :
E-Posters Discussion - Counter 2
Room :
E-POSTERS' AREA
P070
10h15 - 10h20
10h15 - 10h20
THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PRCL-02 IN HEALTHY VOLUNTEERS AND PATIENTS WITH CHRONIC PLAQUE PSORIASIS
Kim A. PAPP - Canada
Kim A. PAPP - Canada
P069
10h10 - 10h10
10h10 - 10h10
COMPLETE CLEARANCE AND CUMULATIVE BENEFIT BY PSORIASIS AREA AND SEVERITY INDEX (PASI) FOR BRODALUMAB AND USTEKINUMAB IN AMAGINE-2 AND -3
Richard WARREN - United Kingdom
Richard WARREN - United Kingdom
P071
10h20 - 10h25
10h20 - 10h25
APREMILAST IN PALMOPLANTAR PSORIASIS
Pujol Montcusi JOSEP
Pujol Montcusi JOSEP